Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P5IZ
|
||||
Former ID |
DNCL002300
|
||||
Drug Name |
BI-811283
|
||||
Indication | Acute myeloid leukemia [ICD9: 205; ICD10:C92.0] | Phase 1 | [522353] | ||
Company |
Boehringer Ingelheim Pharmaceuticals
|
||||
Target and Pathway | |||||
Target(s) | Aurora kinase B | Target Info | Inhibitor | [531806], [544271] | |
Pathway Interaction Database | Aurora B signaling | ||||
Signaling by Aurora kinases | |||||
Aurora C signaling | |||||
FOXM1 transcription factor network | |||||
Aurora A signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.